Peficitinib suppresses diffuse-type tenosynovial giant cell tumor by targeting TYK2 and JAK/STAT signaling

Shan Lu(Peking University), Yan Zhang(Dalian Medical University), Kaiping Liu(Peking University), Zhijun Wu(Peking University), Hongjie Huang(Peking University), Dingge Liu(Peking University), Erdan Dong(Qingdao University), Xin Zhang(Sichuan Cancer Hospital), H. J. Yang(Ministry of Education of the People's Republic of China), Zhihua Zhang(Anhui Medical University), Haijun Wang(Jilin University), Jiayi Li(Peking University), Gang Yang(Peking University), Wenjia Zhang(Tongji University), Hui Dai(Ganzhou People's Hospital), Chenxi Cao(Peking University), Yingjia Li(Guangzhou University of Chinese Medicine), Xi Gong(Peking University), Yong‐Jian Wang(Peking University)
Science China Life Sciences
January 8, 2025
Cited by 5


Related Papers